Publikationen in Zusammenarbeit mit Forschern von Radboud University Nijmegen Medical Centre (7)

2021

  1. Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality (Molecular Psychiatry, (2020), 25, 10, (2493-2503), 10.1038/s41380-018-0339-3)

    Molecular Psychiatry

  2. Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder

    Nature Communications, Vol. 12, Núm. 1

  3. Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2101-2110

2020

  1. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality

    Molecular Psychiatry, Vol. 25, Núm. 10, pp. 2493-2503

  2. Shared genetic background between children and adults with attention deficit/hyperactivity disorder

    Neuropsychopharmacology, Vol. 45, Núm. 10, pp. 1617-1626

2019

  1. Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells

    Neuropsychopharmacology, Vol. 44, Núm. 5, pp. 890-897

2018

  1. Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

    Scientific Reports, Vol. 8, Núm. 1